TUESDAY, Jan. 26 (HealthDay News) -- Morphine Sulfate Oral Solution has been approved by the U.S. Food and Drug Administration to treat acute and chronic pain. Sanctioned doses are 100 milligrams per 5 mL and 20 milligrams per 1 mL, the agency said in a news release.
Although the drug has been prescribed for this use "for many years," the agency said, this form and concentration hadn't been approved until now.
The painkiller was sanctioned as part of the agency's unapproved drug initiative to "make sure marketed drugs meet current FDA standards," the news release said.
The drug is manufactured by Ohio-based Roxane Laboratories, a unit of Boehringer Ingelheim.
More information
To learn more about morphine sulfate, visit the U.S. National Institutes of Health.
Programs & Services
For Women
For Men
For Patients
For the Community
